- Home
- About
- Find staff
- Per-Ola Andersson
Per-Ola Andersson
Adjunct Professor
Department of Internal Medicine and Clinical-
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell
therapy
Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Kristina Sonnevi, Maria Ljungqvist, Birgitta Sander, Mats Jerkeman, Karin E. Smedby
LEUKEMIA & LYMPHOMA - 2023 -
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte
globulin
Mikael Lisak, Malin Nicklasson, Robert Palmason, Stina Wichert, Cecila Isaksson, Per-Ola Andersson, Jan-Erik Johansson, Stig Lenhoff, Mats Brune, Markus Hansson
Scientific Reports - 2023 -
Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation
Recipients
Sigrun Einarsdottir, Ingigerdur Sverrisdottir, Krista Vaht, Tomas Bergström, Mats Brune, Per-Ola Andersson, C. Wenneras, P. Ljungman
Transplantation and Cellular Therapy - 2023 -
Bone marrow expression of CD68/CD163 macrophages, IL-17 and FOXP3 cells in aplastic anemia and their relation to
prognosis
Krista Vaht, J. Brenner, Susanne Bram Ednersson, P. Ljungman, Mats Brune, Per-Ola Andersson
European Journal of Haematology - 2023 -
Artificial Intelligence Increases the Agreement among Physicians Classifying Focal Skeleton/Bone Marrow Uptake in Hodgkin's Lymphoma Patients Staged with F-18 FDG PET/CT-a Retrospective
Study
May Sadik, Jesus Lopez-Urdaneta, J. Ulen, O. Enqvist, Per-Ola Andersson, R. Kumar, E. Tragardh
Nuclear Medicine and Molecular Imaging - 2023 -
Outcomes in patients with chest pain in emergency departments using high-sensitivity versus conventional
troponins
Maria Odqvist, N. Bandstein, Hans Tygesen, K. M. Eggers, Per-Ola Andersson, M. J. Holzmann
Scandinavian Cardiovascular Journal - 2023 -
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture
technology
A. Skaftason, Y. Qu, M. Abdulla, J. Nordlund, M. Berglund, Susanne Bram Ednersson, Per-Ola Andersson, G. Enblad, R. M. Amini, R. Rosenquist, L. Mansouri
Genes Chromosomes & Cancer - 2022 -
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736
patients
S. Harrysson, S. Eloranta, S. Ekberg, G. Enblad, T. C. El-Galaly, B. Sander, K. Sonnevi, Per-Ola Andersson, M. Jerkeman, K. E. Smedby
British Journal of Haematology - 2022 -
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in
Sweden
S. Harrysson, S. Eloranta, S. Ekberg, G. Enblad, M. Jerkeman, B. E. Wahlin, Per-Ola Andersson, K. E. Smedby
Blood Cancer Journal - 2021 -
Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell
transplantation.
Ljupco Veskovski, Per-Ola Andersson, Ingemar Turesson, Daniel Malmodin, Anders Pedersen, Ulf-Henrik Mellqvist
Experimental hematology - 2021 -
Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype
patients
Susanne Bram Ednersson, Mimmi Stern, Henrik Fagman, Herman Nilsson-Ehle, S. Hasselblom, Annika Thorsell, Per-Ola Andersson
Leukemia & Lymphoma - 2021 -
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort
study
S. Ekberg, S. Harrysson, T. Jernberg, K. Szummer, Per-Ola Andersson, M. Jerkeman, K. E. Smedby, S. Eloranta
Journal of Internal Medicine - 2021 -
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based
study
A. Abu Sabaa, C. Morth, S. Hasselblom, G. Hedstrom, M. Flogegard, Mimmi Stern, Per-Ola Andersson, I. Glimelius, G. Enblad
British Journal of Haematology - 2021 -
TBLR1 and CREBBP as potential novel prognostic immunohistochemical biomarkers in diffuse large B-cell
lymphoma
Susanne Bram Ednersson, Mimmi Stern, Henrik Fagman, Herman Nilsson-Ehle, Sverker Hasselblom, Per-Ola Andersson
Leukemia & Lymphoma - 2020 -
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell
lymphoma
T. Wasterlid, S. Harrysson, T. M. L. Andersson, S. Ekberg, G. Enblad, Per-Ola Andersson, M. Jerkeman, S. Eloranta, K. E. Smedby
American Journal of Hematology - 2020 -
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell
lymphoma
M. Abdulla, P. Hollander, T. Pandzic, L. Mansouri, S. B. Ednersson, Per-Ola Andersson, M. Hultdin, M. Fors, M. Erlanson, S. Degerman, H. M. Petersen, F. Asmar, K. Gronbaek, G. Enblad, L. Cavelier, R. Rosenquist, R. M. Amini
American Journal of Hematology - 2020 -
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort
Study
Krista Vaht, M. Göransson, K. Carlson, C. Isaksson, S. Lenhoff, A. Sandstedt, B. Uggla, J. Winiarski, P. Ljungman, Per-Ola Andersson, Mats Brune
Biology of Blood and Marrow Transplantation - 2019 -
Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic
leukemia.
Sara Wernig-Zorc, Mukesh Pratap Yadav, Pradeep Kumar Kopparapu, Mats Bemark, Hallgerdur Lind Kristjansdottir, Per-Ola Andersson, Chandrasekhar Kanduri, Meena Kanduri
Epigenetics & chromatin - 2019 -
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell
lymphoma
S. Ekberg, M. Jerkeman, Per-Ola Andersson, G. Enblad, B. E. Wahlin, S. Hasselblom, T. M. Andersson, S. Eloranta, K. E. Smedby
American Journal of Hematology - 2018 -
Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma
patients
Susanne Bram Ednersson, Martin Stenson, Mimmi Stern, G. Enblad, Henrik Fagman, Herman Nilsson-Ehle, Sverker Hasselblom, Per-Ola Andersson
British Journal of Haematology - 2018 -
Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - a Swedish nationwide cohort
study.
Krista Vaht, Magnus Göransson, Kristina Carlson, Cecilia Isaksson, Stig Lenhoff, Anna Sandstedt, Bertil Uggla, Jacek Winiarski, Per Ljungman, Mats Brune, Per-Ola Andersson
European journal of haematology - 2018 -
High-Sensitivity Troponins and Outcomes After Myocardial
Infarction
Maria Odqvist, Per-Ola Andersson, Hans Tygesen, K. M. Eggers, M. J. Holzmann
Journal of the American College of Cardiology - 2018 -
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from
2000-2011
Krista Vaht, M. Goransson, K. Carlson, C. Isaksson, S. Lenhoff, A. Sandstedt, B. Uggla, J. Winiarski, P. Ljungman, Mats Brune, Per-Ola Andersson
Haematologica - 2017 -
Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL
cells
Olle Werlenius, Johan Aurelius, Alexander Hallner, Aliasghar Akhiani, Maria Simpanen, Anna Martner, Per-Ola Andersson, Kristoffer Hellstrand, Fredrik Bergh Thorén
Oncotarget - 2016 -
Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in
CLL.
Santhilal Subhash, Per-Ola Andersson, Subazini Thankaswamy Kosalai, Chandrasekhar Kanduri, Meena Kanduri
Clinical Epigenetics - 2016 -
Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot
study.
Martin Stenson, Anders Pedersen, Sverker Hasselblom, Herman Nilsson-Ehle, B Göran Karlsson, Rui Pinto, Per-Ola Andersson
Leukemia & lymphoma - 2016 -
MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic lymphocytic
leukemia.
Pradeep Kumar Kopparapu, Caroline Miranda, Linda Fogelstrand, Kankadeb Mishra, Per-Ola Andersson, Chandrasekhar Kanduri, Meena Kanduri
The FEBS journal - 2015 -
SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma
Patients.
Ulla Rüetschi, Martin Stenson, Sverker Hasselblom, Herman Nilsson-Ehle, Ulrika Hansson, Henrik Fagman, Per-Ola Andersson
International journal of proteomics - 2015 -
Severe infusion-related reactions are uncommon in rituximab-treated CLL patients in clinical practice: results from a Swedish national observational
study.
Stefan Norin, Bo Björkstrand, Franz Rommel, Lars Timberg, Per-Ola Andersson, Johan Häggström, Anders Aldrin, Lotta Hansson
Leukemia research - 2015 -
High Functional CD70 Expression on α-Type 1-Polarized Dendritic Cells from Patients with Chronic Lymphocytic
Leukaemia
Katarina Junevik, Olle Werlenius, Linda Fogelstrand, Alex Karlsson-Parra, Per-Ola Andersson
Scandinavian Journal of Immunology - 2014 -
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation
profiles.
Meena Kanduri, Millaray Marincevic, Anna M Halldórsdóttir, Larry Mansouri, Katarina Junevik, Stavroula Ntoufa, Hanna Göransson Kultima, Anders Isaksson, Gunnar Juliusson, Per-Ola Andersson, Hans Ehrencrona, Kostas Stamatopoulos, Richard Rosenquist
Epigenetics : official journal of the DNA Methylation Society - 2012 -
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate
cancer.
Sören Lehmann, Vladimir J N Bykov, Dina Ali, Ove Andrén, Honar Cherif, Ulf Tidefelt, Bertil Uggla, Jeffrey Yachnin, Gunnar Juliusson, Ali Moshfegh, Christer Paul, Klas G Wiman, Per-Ola Andersson
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 2012 -
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation
profiles.
Meena Kanduri, Millaray Marincevic, Anna M. Halldórsdóttir, Larry Mansouri, Katarina Junevik, Stavroula Ntoufa, Hanna Göransson Kultima, Anders Isaksson, Gunnar Juliusson, Per-Ola Andersson, Hans Ehrencrona, Kostas Stamatopoulos, Richard Rosenquist
Epigenetics - 2012 -
Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy
era
Sverker Hasselblom, Martin Stenson, Olle Werlenius, Monica Sender Baum, Catharina Lewerin, Ulrika Hansson, Herman Nilsson-Ehle, Per-Ola Andersson
Leukemia and Lymphoma - 2012 -
Tumour-loaded alpha-type 1-polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia Produce a Superior NK-, NKT- and CD8(+) T Cell-attracting Chemokine
Profile
Karin Gustafsson, Katarina Junevik, Olle Werlenius, Sandra Holmgren, Alex Karlsson-Parra, Per-Ola Andersson
Scandinavian Journal of Immunology - 2011 -
Melphalan 100 mg/m(2) with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell
transplantation.
Cecilie Blimark, Ljupco Veskovski, Jan Westin, Stig Rödjer, Mats Brune, Martin Hjorth, Erik Holmberg, Per-Ola Andersson, Ulf-Henrik Mellqvist
European journal of haematology - 2011 -
The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia
(B-CLL).
Katarina Junevik, Olle Werlenius, Sverker Hasselblom, Stefan Jacobsson, Herman Nilsson-Ehle, Per-Ola Andersson
Annals of hematology - 2007 -
Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic
purpura.
Bob Olsson, Per-Ola Andersson, Stefan Jacobsson, Lena M S Carlsson, Hans Wadenvik
Thrombosis and haemostasis - 2005 -
Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for
therapy.
Per-Ola Andersson, Hans Wadenvik
Expert reviews in molecular medicine - 2004 -
On cellular immunology in chronic idiopathic thrombocytopenic purpura
(ITP)
Per-Ola Andersson
2003 -
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic
purpura.
Bob Olsson, Per-Ola Andersson, Margareta Jernås, Stefan Jacobsson, Björn Carlsson, Lena M S Carlsson, Hans Wadenvik
Nature medicine - 2003 -
Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic
purpura.
Per-Ola Andersson, Anna Olsson, Hans Wadenvik
British journal of haematology - 2002 -
Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet
function.
Anna Olsson, Per-Ola Andersson, Lilian Tengborn, Hans Wadenvik
Thrombosis research - 2002 -
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic
leukaemia.
P Wernstedt, Mats Brune, Per-Ola Andersson, B Gustavsson, Dick Stockelberg, Hans Wadenvik
Bone marrow transplantation - 2002 -
Plasma thrombopoietin concentrations in response to platelet transfusion
therapy.
P Möller, Per-Ola Andersson, A C Andersson, Hans Wadenvik
Acta haematologica - 2000 -
Leukemic transformation of essential thrombocythemia without previous cytoreductive
treatment.
Per-Ola Andersson, Börje Ridell, Hans Wadenvik, Jack Kutti
Annals of hematology - 2000 -
A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic
purpura.
Per-Ola Andersson, Dick Stockelberg, Stefan Jacobsson, Hans Wadenvik
Annals of hematology - 2000 -
Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow
megakaryocytes.
M Hou, Per-Ola Andersson, Dick Stockelberg, Ulf-Henrik Mellqvist, Börje Ridell, Hans Wadenvik
British journal of haematology - 1998 -
[A forgotten fraudulent bean--a case of favism. Fava bean may cause life-threatening hemolysis in predisposed
persons]
Per-Ola Andersson, Stefan Jacobsson, Hans Wadenvik
Läkartidningen - 1998